West Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and Participation in Upcoming Investor Conference
West Pharmaceutical Services has declared a $0.17 dividend per share for Q1 2021, payable on February 3, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West Pharmaceutical Services has declared a $0.17 dividend per share for Q1 2021, payable on February 3, 2021. Shareholders of record by January 20, 2021 will receive the dividend. Additionally, the Board has authorized a share repurchase program for up to 631,000 shares in 2021, aimed at enhancing shareholder value. The program will be completed by December 31, 2021. West will also present at the J.P. Morgan Healthcare Conference on January 13, 2021, offering insights into its business.
Positive
- Dividend of $0.17 per share increases shareholder returns.
- Share repurchase program of up to 631,000 shares may enhance EPS and shareholder value.
Negative
- None.
Details
News Market Reaction – WST
The recorded move for WST in the trading session of this news was -2.29%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EXTON, Pa., Dec. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2021 dividend of
On December 8, 2020, the Company's Board of Directors authorized a share repurchase program for calendar-year 2021 of up to 631,000 shares of the Company's common stock from time to time on the open market or in privately-negotiated transactions, as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. The share repurchase program is expected to be completed by December 31, 2021. The Company's previously-authorized share repurchase program will expire on December 31, 2020.
The Company also announced that management will be presenting an overview of the business at the J.P. Morgan Healthcare Conference at 5:20 p.m. EST on Wednesday, January 13, 2021. A live audio webcast of the presentations and a copy of the presentation materials will be accessible from the Company's website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2019 sales of
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-announces-first-quarter-2021-dividend-2021-share-repurchase-program-and-participation-in-upcoming-investor-conference-301189021.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.